303 related articles for article (PubMed ID: 33560416)
1. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
Barajas RF; Politi LS; Anzalone N; Schöder H; Fox CP; Boxerman JL; Kaufmann TJ; Quarles CC; Ellingson BM; Auer D; Andronesi OC; Ferreri AJM; Mrugala MM; Grommes C; Neuwelt EA; Ambady P; Rubenstein JL; Illerhaus G; Nagane M; Batchelor TT; Hu LS
Neuro Oncol; 2021 Jul; 23(7):1056-1071. PubMed ID: 33560416
[TBL] [Abstract][Full Text] [Related]
2. Imaging features (CT, MRI, MRS, and PET/CT) of primary central nervous system lymphoma in immunocompetent patients.
Cheng G; Zhang J
Neurol Sci; 2019 Mar; 40(3):535-542. PubMed ID: 30580380
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma: advances in MRI and PET imaging.
Ambady P; Hu LS; Politi LS; Anzalone N; Barajas RF
Ann Lymphoma; 2021 Sep; 5():. PubMed ID: 35994050
[TBL] [Abstract][Full Text] [Related]
4. Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis.
Matsuzono K; Yagisawa T; Ohtani K; Ishishita Y; Yamaguchi T; Mashiko T; Ozawa T; Koide R; Tanaka R; Kawai K; Fujimoto S
J Int Med Res; 2021 Aug; 49(8):3000605211035197. PubMed ID: 34461767
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
[TBL] [Abstract][Full Text] [Related]
6. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
Choi YS; Lee HJ; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
[TBL] [Abstract][Full Text] [Related]
8.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
9. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid
Zhang S; Wang J; Wang K; Li X; Zhao X; Chen Q; Zhang W; Ai L
Eur J Radiol; 2022 May; 150():110235. PubMed ID: 35290912
[TBL] [Abstract][Full Text] [Related]
12. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
Miyakita Y; Ohno M; Takahashi M; Kurihara H; Katai H; Narita Y
Jpn J Clin Oncol; 2020 May; 50(5):512-518. PubMed ID: 32129443
[TBL] [Abstract][Full Text] [Related]
14. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
Inoue A; Matsumoto S; Ohnishi T; Miyazaki Y; Kinnami S; Kanno K; Honda T; Kurata M; Taniwaki M; Kusakabe K; Suehiro S; Yamashita D; Shigekawa S; Watanabe H; Kitazawa R; Kunieda T
World Neurosurg; 2023 Apr; 172():e517-e523. PubMed ID: 36690204
[TBL] [Abstract][Full Text] [Related]
15. Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma.
Gupta M; Gupta T; Purandare N; Rangarajan V; Puranik A; Moiyadi A; Shetty P; Epari S; Sahay A; Mahajan A; Janu A; Bagal B; Menon H; Kannan S; Krishnatry R; Sastri GJ; Jalali R
CNS Oncol; 2019 Dec; 8(4):CNS46. PubMed ID: 31779471
[No Abstract] [Full Text] [Related]
16. The utility of body FDG PET in staging primary central nervous system lymphoma.
Mohile NA; Deangelis LM; Abrey LE
Neuro Oncol; 2008 Apr; 10(2):223-8. PubMed ID: 18287338
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging in Central Nervous System Lymphoma.
Nabavizadeh SA; Vossough A; Hajmomenian M; Assadsangabi R; Mohan S
Hematol Oncol Clin North Am; 2016 Aug; 30(4):799-821. PubMed ID: 27443998
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
Kawai N; Miyake K; Yamamoto Y; Nishiyama Y; Tamiya T
Biomed Res Int; 2013; 2013():247152. PubMed ID: 23844359
[TBL] [Abstract][Full Text] [Related]
20. Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study.
Bertaux M; Houillier C; Edeline V; Habert MO; Mokhtari K; Giron A; Bergeret S; Hoang-Xuan K; Cassoux N; Touitou V; Choquet S; Soussain C; Kas A
J Neurooncol; 2020 Jun; 148(2):343-352. PubMed ID: 32405997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]